
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Dr. M has practiced dermatology for 25 years. During that time he has hired and fired secretaries, nurses, and licensed medical assistants.